You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 137 No. 1, January 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (7)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Liver/ Biliary Tract/ Pancreatic Diseases
 •Hypertension
 •Immunology
 •Endocrine Surgery
 •Immunology, Other
 •Transplantation, Other
 •Alert me on articles by topic

The Value of Partial Splenic Autotransplantation in Patients With Portal Hypertension

A Prospective Randomized Study

Hongwei Zhang, MD; Jisheng Chen, MD; Gernot M. Kaiser, MD; Obetien Mapudengo, MD; Jie Zhang, MD; Michael S. Exton, PhD; Erwei Song, MD, PhD

Arch Surg. 2002;137:89-93.

Hypothesis  Splenic autotransplantation plays a role in preserving immune function of the spleen in patients with portal hypertension and liver cirrhosis.

Design  Prospective randomized study.

Setting  University hospital.

Patients  Twenty patients (19 men and 1 woman; aged 33-80 years) suffering from portal hypertension and liver cirrhosis were randomly allocated into 2 groups. Each group consisted of 10 patients.

Interventions  All patients underwent modified Sugiura operation. In the control group, splenectomy was performed, while partial splenic autotransplantation into the retroperitoneal space was additionally completed in the splenic autotransplantation group.

Main Outcome Measures  Serum tuftsin and IgM were measured preoperatively and 2 months after surgery. Dynamic scintigraphy with technetium Tc 99m–labeled heat-damaged erythrocytes was performed at 2-month intervals during the 8-month follow-up.

Results  There was no statistical difference in the mortality of the groups. The preoperative levels of serum tuftsin and IgM showed no statistical difference between groups. However, although these measures had decreased remarkably in the control group 2 months after operation (P<.001 for serum tuftsin; P = .04 for serum IgM), they remained stable in the splenic autotransplantation group (P = .25 for serum tuftsin; P = .12 for serum IgM). Four patients within the splenic autotransplantation group showed positive scanning of the transplanted splenic fragment during follow-up, whereas there was no positive scanning in the control group.

Conclusion  Our results suggest that partial splenic autotransplantation can preserve immune function of the spleen, as measured by serum levels of tuftsin and IgM, in patients with portal hypertension and liver cirrhosis.


From the Department of General Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University of Medical Sciences, Guangzhou, Peoples Republic of China (Drs H. Zhang, Chen, Mapudengo, J. Zhang, and Song); and Departments of General Surgery and Transplantation (Drs H. Zhang and Kaiser) and Medical Psychology (Dr Exton), University Hospital Essen, Essen, Germany.


RELATED ARTICLES

This Month in Archives of Surgery
Arch Surg. 2002;137(1):10.
FULL TEXT  

Archives of Surgery Reader's Choice: Continuing Medical Education
Arch Surg. 2002;137(1):116-117.
FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.